Moreover, targeting CXCR3 was proposed as a strategy to prevent metastatic formation in breast cancer through the inhibition of CXCR3-dependent cancer cell migration and the enhancement of host antitumor immunity [66]. The gene discussed is CXCR3; the disease is breast cancer.